<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00987051</url>
  </required_header>
  <id_info>
    <org_study_id>P060229</org_study_id>
    <nct_id>NCT00987051</nct_id>
  </id_info>
  <brief_title>Sentinel Node and Endometrial Cancer</brief_title>
  <acronym>Senti-Endo</acronym>
  <official_title>Validation of the Sentinel Node in Endometrial Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the relevance of sentinel node in endometrial
      cancer. Sentinel node is thought to reflect the status of lymph node. Only 10 to 20% of women
      with endometrial cancer exhibit lymph node metastasis hence systematic lymphadenectomy is
      questionable. In breast cancer, melanoma and vulvar cancer, sentinel node has emerged as an
      alternative to complete lymphadenectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the relevance of sentinel node in endometrial cancer. Sentinel node is though
      to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit
      lymph node metastasis hence systematic lymphadenectomy is questionable. In breast cancer,
      melanoma and vulvar cancer, sentinel node has emerged as an alternative to complete
      lymphadenectomy. The objective of our trial is to validate the concept of sentinel node in
      endometrial cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection and false negative rates of sentinel node</measure>
    <time_frame>During the surgery (hysterectomy)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity and recurrence rates</measure>
    <time_frame>During 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Endometrial Neoplasms</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with endometrial cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Detection of sentinel node</intervention_name>
    <description>Coelioscopy or laparotomy (based on the tumor size) after a colorimetric tracer injection</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient over 18 years old with a surgery planned for endometrial cancer

          -  endometrial cancer proved by biopsy

          -  early stage of endometrial cancer (FIGO stage 1-2)

          -  without contraindication to surgery

          -  inform consent signed

          -  affiliated to general health system

        Exclusion Criteria:

          -  endometrial cancer FIGO stages 3-4

          -  previous history of surgery modifying lymphatic drainage (conization myomectomy)

          -  pregnant women or breast feeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emile DARAÏ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tenon Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2009</study_first_submitted>
  <study_first_submitted_qc>September 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2009</study_first_posted>
  <last_update_submitted>December 10, 2012</last_update_submitted>
  <last_update_submitted_qc>December 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sentinel node procedure</keyword>
  <keyword>radiocolloid</keyword>
  <keyword>patent blue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

